Directors buying more shares on market (albeit small parcels) but it shows that management is confident that 30c seems too low for 2016/2017 FY predictions.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025